Aptahem AB (publ) (NGM:APTA)
Sweden · Delayed Price · Currency is SEK 0.8700
-0.0760 (-8.03%)
At close: Mar 18, 2026
Aptahem AB Revenue
In the year 2025, Aptahem AB had annual revenue of 2.59M SEK, down -32.73%. Aptahem AB had revenue of 829.09K in the quarter ending December 31, 2025, with 4.98% growth.
Revenue
2.59M
Revenue Growth
-32.73%
P/S Ratio
7.06
Revenue / Employee
861.70K
Employees
3
Market Cap
18.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.59M | -1.26M | -32.73% |
| Dec 31, 2024 | 3.84M | -6.62M | -63.28% |
| Dec 31, 2023 | 10.46M | 7.02M | 203.47% |
| Dec 31, 2022 | 3.45M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanologica AB | 21.13M |
| Fluicell AB | 15.22M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| AcouSort AB | 10.43M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
| NanoEcho AB | 487.00K |
| Stayble Therapeutics AB | 47.00K |